Brooke M. Katzman

545 total citations
26 papers, 406 citations indexed

About

Brooke M. Katzman is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Brooke M. Katzman has authored 26 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Oncology. Recurrent topics in Brooke M. Katzman's work include Clinical Laboratory Practices and Quality Control (6 papers), Chemokine receptors and signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Brooke M. Katzman is often cited by papers focused on Clinical Laboratory Practices and Quality Control (6 papers), Chemokine receptors and signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Brooke M. Katzman collaborates with scholars based in United States and Canada. Brooke M. Katzman's co-authors include Dennis C. Liotta, Leslie J. Donato, Allan S. Jaffe, Stephen F. Traynelis, N Baumann, Alan J. Lueke, Lawrence J. Wilson, Ana A. Alcaraz, James P. Snyder and Timothy M. Acker and has published in prestigious journals such as Journal of Medicinal Chemistry, Clinical Chemistry and Molecular Pharmacology.

In The Last Decade

Brooke M. Katzman

25 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brooke M. Katzman United States 12 186 90 81 78 55 26 406
Todd Shearer United States 12 198 1.1× 40 0.4× 73 0.9× 49 0.6× 23 0.4× 30 485
Shimeng Guo China 15 514 2.8× 174 1.9× 27 0.3× 71 0.9× 31 0.6× 55 728
Nigel Beaton Switzerland 10 239 1.3× 30 0.3× 55 0.7× 23 0.3× 30 0.5× 17 517
Kathleen M. S. E. Reyskens United Kingdom 9 156 0.8× 36 0.4× 20 0.2× 68 0.9× 41 0.7× 11 398
Ramón Yarza Spain 7 175 0.9× 57 0.6× 23 0.3× 129 1.7× 47 0.9× 17 490
H. Koester Germany 8 368 2.0× 17 0.2× 30 0.4× 50 0.6× 28 0.5× 11 577
Thomas Schroeter United States 7 279 1.5× 30 0.3× 122 1.5× 49 0.6× 18 0.3× 10 422
Calvin Yee United States 11 287 1.5× 149 1.7× 11 0.1× 122 1.6× 72 1.3× 13 672
Linlin Ma China 11 224 1.2× 14 0.2× 28 0.3× 29 0.4× 65 1.2× 20 472
Peter Kupchak Canada 11 360 1.9× 42 0.5× 36 0.4× 47 0.6× 25 0.5× 17 624

Countries citing papers authored by Brooke M. Katzman

Since Specialization
Citations

This map shows the geographic impact of Brooke M. Katzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke M. Katzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke M. Katzman more than expected).

Fields of papers citing papers by Brooke M. Katzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke M. Katzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke M. Katzman. The network helps show where Brooke M. Katzman may publish in the future.

Co-authorship network of co-authors of Brooke M. Katzman

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke M. Katzman. A scholar is included among the top collaborators of Brooke M. Katzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke M. Katzman. Brooke M. Katzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winston‐McPherson, Gabrielle, Tiffany Thomas, Matthew D. Krasowski, et al.. (2025). Estradiol Concentrations for Adequate Gender-Affirming Feminizing Therapy: A Systematic Review. LGBT Health. 12(7). 477–489. 1 indexed citations
2.
Katzman, Brooke M., et al.. (2024). Promoting Health Equity Through Effective Laboratory Stewardship Strategies. Clinics in Laboratory Medicine. 44(4). 665–677. 1 indexed citations
3.
4.
Perszyk, Riley E., Tue G. Banke, Jing Zhang, et al.. (2021). The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-d-Aspartate Receptors. Molecular Pharmacology. 99(5). 399–411. 11 indexed citations
5.
Donato, Leslie J., et al.. (2021). Analytical and Clinical Considerations in Implementing the Roche Elecsys Troponin T Gen 5 STAT Assay. American Journal of Clinical Pathology. 156(6). 1121–1129. 9 indexed citations
6.
Katzman, Brooke M., et al.. (2021). Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing. The Journal of Applied Laboratory Medicine. 6(4). 992–997. 3 indexed citations
7.
Katzman, Brooke M., et al.. (2021). Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test. Clinical Biochemistry. 117. 1–3. 14 indexed citations
8.
Katzman, Brooke M. & Brad S. Karon. (2020). Test Utilization Proposal for Reflex Bilirubin Testing: Why Order Two Tests When One Will Do?. The Journal of Applied Laboratory Medicine. 6(4). 980–984. 1 indexed citations
9.
10.
Bowen, Raffick A.R., Jessica M Colón-Franco, Brooke M. Katzman, et al.. (2019). Best practices in mitigating the risk of biotin interference with laboratory testing. Clinical Biochemistry. 74. 1–11. 38 indexed citations
11.
Katzman, Brooke M., et al.. (2019). Estimating short- and long-term reference change values and index of individuality for tests of platelet function. Clinical Biochemistry. 74. 54–59. 3 indexed citations
12.
Katzman, Brooke M., et al.. (2019). Real-Time Detection of Analytical Outliers on the Roche Troponin T Generation 5 Assay. American Journal of Clinical Pathology. 152(Supplement_1). S83–S83. 1 indexed citations
13.
Katzman, Brooke M., Alan J. Lueke, Leslie J. Donato, Allan S. Jaffe, & N Baumann. (2018). Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clinical Biochemistry. 60. 11–16. 57 indexed citations
14.
Huang, Ming‐Bo, et al.. (2018). Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells. Oncotarget. 9(24). 16996–17013. 8 indexed citations
15.
Katzman, Brooke M., et al.. (2017). Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences. Clinical Biochemistry. 50(13-14). 768–771. 20 indexed citations
16.
Katzman, Brooke M., Riley E. Perszyk, Hongjie Yuan, et al.. (2015). A novel class of negative allosteric modulators of NMDA receptor function. Bioorganic & Medicinal Chemistry Letters. 25(23). 5583–5588. 14 indexed citations
17.
Katzman, Brooke M., et al.. (2015). 55: Evaluation of the Clinical and Laboratory Standards Institute EP26-A Guideline: A Protocol for Reagent Lot-to-Lot Verification. American Journal of Clinical Pathology. 143(suppl_1). A028–A028. 1 indexed citations
18.
Mills, John R., et al.. (2015). 72: Exploring Associations Between Genotype and Serology in Celiac Disease. American Journal of Clinical Pathology. 143(suppl_1). A042–A042. 2 indexed citations
19.
Zhao, Huanyu, Brooke M. Katzman, Ana A. Alcaraz, et al.. (2013). Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists. ACS Medicinal Chemistry Letters. 4(11). 1025–1030. 55 indexed citations
20.
Acker, Timothy M., et al.. (2012). Novel NMDA receptor modulators: an update. Expert Opinion on Therapeutic Patents. 22(11). 1337–1352. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd Shearer Breakdown of academic impact, for papers by Shimeng Guo Breakdown of academic impact, for papers by Nigel Beaton Breakdown of academic impact, for papers by Kathleen M. S. E. Reyskens Breakdown of academic impact, for papers by Ramón Yarza Breakdown of academic impact, for papers by H. Koester Breakdown of academic impact, for papers by Thomas Schroeter Breakdown of academic impact, for papers by Calvin Yee Breakdown of academic impact, for papers by Linlin Ma Breakdown of academic impact, for papers by Peter Kupchak
Rankless by CCL
2026